Ardizzoni A - Search Results

1

Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines.

Fumarola C, Bozza N, Castelli R, Ferlenghi F, Marseglia G, Lodola A, Bonelli M, La Monica S, Cretella D, Alfieri R, Minari R, Galetti M, Tiseo M, Ardizzoni A, Mor M, Petronini PG. Fumarola C, et al. Among authors: ardizzoni a. Front Oncol. 2019 Mar 26;9:179. doi: 10.3389/fonc.2019.00179. eCollection 2019. Front Oncol. 2019. PMID: 30972293 Free PMC article.

2

Epidermal growth factor receptor targeted therapy by ZD 1839 (Iressa) in patients with brain metastases from non-small cell lung cancer (NSCLC).

Cappuzzo F, Ardizzoni A, Soto-Parra H, Gridelli C, Maione P, Tiseo M, Calandri C, Bartolini S, Santoro A, Crinò L. Cappuzzo F, et al. Among authors: ardizzoni a. Lung Cancer. 2003 Aug;41(2):227-31. doi: 10.1016/s0169-5002(03)00189-2. Lung Cancer. 2003. PMID: 12871787 Clinical Trial.

3

Epidermal growth factor receptor inhibitors: a new prospective in the treatment of lung cancer.

Tiseo M, Loprevite M, Ardizzoni A. Tiseo M, et al. Among authors: ardizzoni a. Curr Med Chem Anticancer Agents. 2004 Mar;4(2):139-48. doi: 10.2174/1568011043482106. Curr Med Chem Anticancer Agents. 2004. PMID: 15032719 Review.

4

Predictors of clinical response of non-small cell cancer to gefitinib.

Ardizzoni A, Tiseo M. Ardizzoni A, et al. JAMA. 2004 Apr 7;291(13):1563; author reply 1563-4. doi: 10.1001/jama.291.13.1563-a. JAMA. 2004. PMID: 15069041 No abstract available.

5

Induction chemotherapy with carboplatin-paclitaxel followed by standard radiotherapy with concurrent daily low-dose cisplatin plus weekly paclitaxel for inoperable non-small-cell lung cancer.

Ardizzoni A, Scolaro T, Mereu C, Cafferata MA, Tixi L, Bacigalupo A, Tiseo M, Monetti F, Rosso R. Ardizzoni A, et al. Am J Clin Oncol. 2005 Feb;28(1):58-64. doi: 10.1097/01.coc.0000139486.24747.26. Am J Clin Oncol. 2005. PMID: 15685036 Clinical Trial.

6

Second-line chemotherapy in the treatment of advanced non-small cell lung cancer (NSCLC).

Ardizzoni A, Tiseo M. Ardizzoni A, et al. J Chemother. 2004 Nov;16 Suppl 4:104-7. doi: 10.1179/joc.2004.16.Supplement-1.104. J Chemother. 2004. PMID: 15688623 Review.

7

CASE 1. Complete remission to corticosteroids in an octreotide-refractory thymoma.

Tiseo M, Monetti F, Ferrarini M, Serrano J, Chiaramondia M, Ardizzoni A. Tiseo M, et al. Among authors: ardizzoni a. J Clin Oncol. 2005 Mar 1;23(7):1578-9. doi: 10.1200/JCO.2005.03.115. J Clin Oncol. 2005. PMID: 15735133 No abstract available.

8

In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines.

Loprevite M, Tiseo M, Grossi F, Scolaro T, Semino C, Pandolfi A, Favoni R, Ardizzoni A. Loprevite M, et al. Among authors: ardizzoni a. Oncol Res. 2005;15(1):39-48. doi: 10.3727/096504005775082066. Oncol Res. 2005. PMID: 15839304

9

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

Tiseo M, Boni L, Ardizzoni A. Tiseo M, et al. Among authors: ardizzoni a. J Clin Oncol. 2005 Sep 1;23(25):6276-7; author reply 6277-8. doi: 10.1200/JCO.2005.02.0156. J Clin Oncol. 2005. PMID: 16135504 No abstract available.

10

Adjuvant chemotherapy for non-small cell lung cancer: ready for clinical practice?

Tiseo M, Franciosi V, Grossi F, Ardizzoni A. Tiseo M, et al. Among authors: ardizzoni a. Eur J Cancer. 2006 Jan;42(1):8-16. doi: 10.1016/j.ejca.2005.08.031. Epub 2005 Nov 15. Eur J Cancer. 2006. PMID: 16293409 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page